In last trading session, X4 Pharmaceuticals Inc (NASDAQ:XFOR) saw 3.55 million shares changing hands with its beta currently measuring 0.42. Company’s recent per share price level of $1.11 trading at -$0.01 or -1.34% at ring of the bell on the day assigns it a market valuation of $185.57M. That closing price of XFOR’s stock is at a discount of -132.43% from its 52-week high price of $2.58 and is indicating a premium of 48.65% from its 52-week low price of $0.57. Taking a look at company’s average trading volume volume of 3.09 million if we extend that period to 3-months.

X4 Pharmaceuticals Inc (NASDAQ:XFOR) trade information

Upright in the red during last session for losing -1.34%, in the last five days XFOR remained trading in the red while hitting it’s week-highest on Thursday, 04/25/24 when the stock touched $1.11 price level, adding 13.95% to its value on the day. X4 Pharmaceuticals Inc’s shares saw a change of 31.78% in year-to-date performance and have moved -14.34% in past 5-day. X4 Pharmaceuticals Inc (NASDAQ:XFOR) showed a performance of -19.93% in past 30-days.

X4 Pharmaceuticals Inc (XFOR) estimates and forecasts

Statistics highlight that X4 Pharmaceuticals Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 50.85% of value to its shares in past 6 months, showing an annual growth rate of 15.79% while that of industry is 12.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 73.95% during past 5 years.

XFOR Dividends

X4 Pharmaceuticals Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.